Log in to save to my catalogue

Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Pa...

Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Pa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8238699

Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept Model

About this item

Full title

Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept Model

Publisher

New York: Springer US

Journal title

Child psychiatry and human development, 2021-08, Vol.52 (4), p.654-668

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Angelman syndrome (AS) is a complex, heterogeneous, and life-long neurodevelopmental disorder. Despite the considerable impact on individuals and caregivers, no disease-modifying treatments are available. To support holistic clinical management and the development of AS-specific outcome measures for clinical studies, we conducted primary and second...

Alternative Titles

Full title

Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept Model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8238699

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8238699

Other Identifiers

ISSN

0009-398X

E-ISSN

1573-3327

DOI

10.1007/s10578-020-01051-z

How to access this item